Labcorp Holdings Inc. last reported quarterly results on Oct 28, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $3.8 billion (+6.9% year over year) and diluted EPS of $3.22. It usually reports 28–48 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 16, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Feb 17, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 28–48 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 28, 2026
28 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
3,810
+6.9%
|
263
+0.7%
|
3.22
+3.2%
|
|
Jul 30, 2026
30 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
3,731
+5.8%
|
299
+25.6%
|
3.64
+28.2%
|
|
Apr 30, 2026
30 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
3,538
+5.8%
|
278
+30.5%
|
3.35
+32.9%
|
|
Feb 17, 2026
48 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
3,516
+5.6%
|
165
+14.9%
|
1.98
+16.1%
|
|
Oct 28, 2025
28 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
3,564
+8.6%
|
261
+54.2%
|
3.12
+56.0%
|
|
Jul 24, 2025
24 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
3,527
+9.5%
|
238
+15.9%
|
2.84
+16.9%
|
|
Apr 29, 2025
29 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
3,345
+5.3%
|
213
-6.7%
|
2.52
-6.3%
|
|
Feb 6, 2025
37 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
3,329
+9.8%
|
143
+185.8%
|
1.71
+187.3%
|
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- LH (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Burlington, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 920148
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS (until May 16, 2024); NATIONAL HEALTH LABORATORIES HOLDINGS INC (until Feb 13, 1995)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.